JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Wadhwa, A. Articles by Young, D. Search for Related Content PubMed PubMed Citation Articles by Wadhwa, A. Articles by Young, D. Related Collections Pain Pharmacology

---

REGIONAL ANESTHESIA AND PAIN MEDICINE

Large-Dose Oral Dextromethorphan as an Adjunct to Patient-Controlled Analgesia with Morphine after Knee Surgery

Monash University Department of Anaesthesia, Clayton, Victoria, Australia and *The Avenue Hospital, Melbourne Victoria

Address correspondence and reprint requests to Professor Colin S. Goodchild, Monash University Department of Anaesthesia, Level 5 Block E, Monash Medical Centre, 246 Clayton Road, Clayton Victoria 3168, Australia. Address e-mail to colin.goodchild @med.monash.edu.au.

Dextromethorphan is a weak N-methyl-d-aspartate (NMDA) receptor antagonist that inhibits spinal cord sensitization in animal models of pain and also inhibits the development of cutaneous secondary hyperalgesia after tissue trauma. Perhaps coadministration of an NMDA antagonist with an opioid would lead to better pain relief, particularly with movement and an opioid-sparing effect. This has been shown for ketamine, but previous studies with dextromethorphan that have used small doses have shown only a modest reduction in morphine requirements with no or minimal changes in the postoperative pain experience. We sought to determine whether a large dose of this drug, just below the maximum tolerated dose, could potentiate morphine analgesia while simultaneously causing a significant improvement in the management of the postoperative pain experience. Sixty-six patients undergoing knee surgery were enrolled in the study. The study design was a prospective, randomized double-blinded comparison with placebo of 200 mg of dextromethorphan given eight hourly. Postoperative pain experiences were assessed by postoperative morphine usage. Visual analog and verbal rating scales were used to assess pain with movement as well as side effects. Dextromethorphan treatment led to a significant but modest reduction in morphine requirements (29.3% P < 0.05) but no reduction in postoperative pain levels. We conclude that increasing orally administered dextromethorphan to near maximum tolerated doses does not provide greater morphine sparing than 20–40 mg given 6–8 hourly as in previous studies. Furthermore we conclude that dextromethorphan does not improve pain scores in a manner expected of a drug with NMDA antagonist properties.

Implications: Although dextromethorphan is an N-methyl-d-aspartate antagonist in animals, this property may not be realizable in human postoperative pain states.

This article has been cited by other articles:

				P. F. White The Changing Role of Non-Opioid Analgesic Techniques in the Management of Postoperative Pain Anesth. Analg., November 1, 2005; 101(5S_Suppl): S5 - 22. [Abstract] [Full Text] [PDF]

				C. J. L. McCartney, A. Sinha, and J. Katz A Qualitative Systematic Review of the Role of N-Methyl-D-Aspartate Receptor Antagonists in Preventive Analgesia Anesth. Analg., May 1, 2004; 98(5): 1385 - 1400. [Abstract] [Full Text] [PDF]

				S. Yamashita, H. Yamaguchi, Y. Hisajima, K. Ijima, K. Saito, A. Chiba, and T. Yasunaga Preoperative Oral Dextromethorphan Attenuated Tourniquet-Induced Arterial Blood Pressure and Heart Rate Increases in Knee Cruciate Ligament Reconstruction Patients Under General Anesthesia Anesth. Analg., April 1, 2004; 98(4): 994 - 998. [Abstract] [Full Text] [PDF]

				D. M. A. Choi, A. P. Kliffer, and M. J. Douglas Dextromethorphan and intrathecal morphine for analgesia after Caesarean section under spinal anaesthesia Br. J. Anaesth., May 1, 2003; 90(5): 653 - 658. [Abstract] [Full Text] [PDF]

				M. F. Davies, F. Haimor, G. Lighthall, and J. D. Clark Dexmedetomidine Fails to Cause Hyperalgesia After Cessation of Chronic Administration Anesth. Analg., January 1, 2003; 96(1): 195 - 200. [Abstract] [Full Text] [PDF]

				A. A. Weinbroum Dextromethorphan Reduces Immediate and Late Postoperative Analgesic Requirements and Improves Patients' Subjective Scorings After Epidural Lidocaine and General Anesthesia Anesth. Analg., June 1, 2002; 94(6): 1547 - 1552. [Abstract] [Full Text] [PDF]

				R. M. Allen, A. L. Granger, and L. A. Dykstra Dextromethorphan Potentiates the Antinociceptive Effects of Morphine and the delta -Opioid Agonist SNC80 in Squirrel Monkeys J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 435 - 441. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999